Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.42 USD | -1.55% | +3.14% | +27.74% |
Apr. 09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
Apr. 08 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.74% | 4.71B | |
+25.24% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.98% | 233B | |
+5.20% | 201B | |
-10.27% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Goldman Sachs Trims Organon & Co's Price Target to $38 From $41, Keeps Buy Rating